Bruce Rutherford
Directeur/Membre du Conseil chez Dentigenix, Inc.
Profil
Bruce Rutherford is currently a Director at Dentigenix, Inc. He was previously a Vice President-Clinical Development at Novalar Pharmaceuticals, Inc. and a Chief Scientific Officer at Dentigenix, Inc. Rutherford holds a doctorate degree from the University of Rochester and an undergraduate degree from the University of Washington.
Postes actifs de Bruce Rutherford
Sociétés | Poste | Début |
---|---|---|
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Bruce Rutherford
Sociétés | Poste | Fin |
---|---|---|
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Formation de Bruce Rutherford
University of Washington | Undergraduate Degree |
Rochester Christian University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Health Technology |